Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
What Happened This Week: Buyback Tax Trend And All Atwitter @ Twitter
08:35pm, Friday, 04'th Nov 2022 Investing.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating ABIOMED, Inc. Buyout
03:55pm, Friday, 04'th Nov 2022
Wilmington, Delaware--(Newsfile Corp. - November 4, 2022) - Rigrodsky Law, P.A. is investigating ABIOMED, Inc. ("ABIOMED") (NASDAQ: ABMD) regarding possible breaches of fiduciary duties and other viol
5 Analysts Have This to Say About Abiomed
06:08pm, Wednesday, 02'nd Nov 2022 Benzinga
Over the past 3 months, 5 analysts have published their opinion on Abiomed (NASDAQ:ABMD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
02:06pm, Wednesday, 02'nd Nov 2022 Benzinga
Upgrades
According to Evercore ISI Group, the prior rating for BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) was changed from In-Line to Outperform. In the third quarter, BioCryst Pharmaceuticals showed
Is Johnson & Johnson an Underrated Growth Stock?
09:50am, Wednesday, 02'nd Nov 2022 The Motley Fool
Johnson & Johnson trades at a modest earnings multiple, and it may warrant a premium.
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
09:07am, Wednesday, 02'nd Nov 2022 Benzinga
Gainers
Abiomed, Inc. (NASDAQ: ABMD) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson & Johnson announced it will acquire the company . Also, the company reported better-than-expec
Gartner, Sony, Uber And Other Big Gainers From Tuesday
06:57am, Wednesday, 02'nd Nov 2022 Benzinga
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.
Abiomed, Inc. (NASDAQ: ABMD) s
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATCO, ABMD, BNFT
05:52am, Wednesday, 02'nd Nov 2022
NEW YORK , Nov. 2, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
Why Abiomed Stock Skyrocketed Today
08:49pm, Tuesday, 01'st Nov 2022 The Motley Fool
A healthcare titan wants to acquire the medical technology specialist for a whopping $16.6 billion.
10 Best Stocks to Buy Now in November
08:02pm, Tuesday, 01'st Nov 2022 The Motley Fool
These beaten-down growth stocks have significant upside.
U.S. stocks end lower as investors weigh economic data, brace for Fed decision on interest rates
07:30pm, Tuesday, 01'st Nov 2022 MarketWatch
U.S. stocks finished lower a day before the conclusion of a two-day Federal Reserve meeting and as the labor market shows little sign of slowing.
Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
06:57pm, Tuesday, 01'st Nov 2022 Benzinga
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 50 points on Tuesday.
The Dow traded down 0.15% to 32,683.95 while the NASDAQ fell 0.55% to 10,927.54. The S&P 50
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C.
Poseidon's $10.9 billion take-private deal for Atlas Corp. sets sail at sweetened price
06:25pm, Tuesday, 01'st Nov 2022 MarketWatch
Buyer Poseidon Acquisition Corp. includes Atlas Corp.'s chairman as well as shipping company Ocean Network Express.
SHAREHOLDER ALERT: Weiss Law Investigates Abiomed, Inc.
05:53pm, Tuesday, 01'st Nov 2022
NEW YORK , Nov. 1, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Abiomed, Inc. ("Abiomed" or the "Compa
